All peptides
Wellness
PT-141
Bremelanotide, studied for libido and sexual-wellness research.
Lyophilized vial
PT-141, also known as bremelanotide, is a melanocortin receptor agonist studied for libido and sexual-wellness applications. Unlike vascular approaches, it acts on central nervous system pathways.
Research focus: Sexual-Wellness Research
Research explores its mechanism through melanocortin signalling and its observed effects on arousal, alongside tolerability and dosing considerations.
Evidence grade
A
Half-life
Presentation
Lyophilized vial
What the research shows — and what it doesn’t
Evidence strength
Grade A: two identical phase 3 randomised placebo-controlled trials, RECONNECT (PMID 31599840), in premenopausal women with hypoactive sexual desire disorder. Note the trials enrolled women only, so the grade does not transfer to men.
Safety context
What a grade does not mean
Safety
Related research
Related research is coming soon for this peptide.